Literature DB >> 12124931

Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain.

Jana Havlasová1, Lenka Hernychová, Petr Halada, Vera Pellantová, Jan Krejsek, Jirí Stulík, Ales Macela, Peter R Jungblut, Pär Larsson, Mats Forsman.   

Abstract

Francisella tularensis subsp. holarctica is the common causal agent of tularemia in Europe. Besides clinical signs, the diagnosis of the disease mostly depends on serological tests. To date, there is a lack of information about the F. tularensis antigens that induce antibody response. Therefore, we have started comprehensive mapping of immunoreactive antigens using the attenuated live vaccine strain of F. tularensis LVS originating from the European virulent strain. For this purpose, the immunoreactivity of sera collected from patients suffering from tularemia, together with the control sera of patients with Lyme disease and healthy blood donors, were examined by means of one-dimensional and two-dimensional immunoblotting. Furthermore, whole cell bacterial lysates, isolated integral membrane proteins and basic proteins were exploited as antigens. By this approach more than 80 different immunorelevant antigens were detected. Most of them came from whole cell bacterial lysate and integral membrane proteins. Conversely, only a negligible reaction was found in the case of basic proteins. Forty-five spots were further selected for mass spectrometric analyses and 22 of them were annotated. Among the spots that provided characteristic reactions with sera from patients with tularemia, 60 kDa and 10 kDa chaperonins that occurred in several charge and mass variants, predominated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124931     DOI: 10.1002/1615-9861(200207)2:7<857::AID-PROT857>3.0.CO;2-L

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  30 in total

Review 1.  ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies.

Authors:  Helen S Garmory; Richard W Titball
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

2.  TLR4-dependent activation of inflammatory cytokine response in macrophages by Francisella elongation factor Tu.

Authors:  Jyotika Sharma; Bibhuti B Mishra; Qun Li; Judy M Teale
Journal:  Cell Immunol       Date:  2011-03-29       Impact factor: 4.868

3.  Proteomic analysis of antibody response in a case of laboratory-acquired infection with Francisella tularensis subsp. tularensis.

Authors:  S Janovská; I Pávková; M Reichelová; M Hubáleka; J Stulík; A Macela
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.099

4.  A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.

Authors:  Qingmei Jia; Richard Bowen; Jacob Sahakian; Barbara Jane Dillon; Marcus A Horwitz
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

5.  Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.

Authors:  Qingmei Jia; Richard Bowen; Bai-Yu Lee; Barbara Jane Dillon; Saša Masleša-Galić; Marcus A Horwitz
Journal:  Vaccine       Date:  2016-08-28       Impact factor: 3.641

Review 6.  An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis.

Authors:  Michael Valentino; John Frelinger
Journal:  Immunol Res       Date:  2009-02-11       Impact factor: 2.829

7.  Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).

Authors:  Susan M Twine; Mireille D Petit; Kelly M Fulton; Robert V House; J Wayne Conlan
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

8.  An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.

Authors:  Chandra Shekhar Bakshi; Meenakshi Malik; Manish Mahawar; Girish S Kirimanjeswara; Karsten R O Hazlett; Lance E Palmer; Martha B Furie; Rajendra Singh; J Andres Melendez; Timothy J Sellati; Dennis W Metzger
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

9.  Identification of an orphan response regulator required for the virulence of Francisella spp. and transcription of pathogenicity island genes.

Authors:  Nrusingh P Mohapatra; Shilpa Soni; Brian L Bell; Richard Warren; Robert K Ernst; Artur Muszynski; Russell W Carlson; John S Gunn
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

10.  Identification of protein candidates for the serodiagnosis of Q fever endocarditis by an immunoproteomic approach.

Authors:  Z Sekeyová; M Kowalczewska; P Decloquement; N Pelletier; E Spitalská; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-17       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.